Mapping the Oxford Shoulder Score onto the EQ-5D utility index.


Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Feb 2023
Historique:
accepted: 18 09 2022
pubmed: 29 9 2022
medline: 14 2 2023
entrez: 28 9 2022
Statut: ppublish

Résumé

In order to enable cost-utility analysis of shoulder pain conditions and treatments, this study aimed to develop and evaluate mapping algorithms to estimate the EQ-5D health index from the Oxford Shoulder Score (OSS) when health outcomes are only assessed with the OSS. 5437 paired OSS and EQ-5D questionnaire responses from four national multicentre randomised controlled trials investigating different shoulder pathologies and treatments were split into training and testing samples. Separate EQ-5D-3L and EQ-5D-5L analyses were undertaken. Transfer to utility (TTU) regression (univariate linear, polynomial, spline, multivariable linear, two-part logistic-linear, tobit and adjusted limited dependent variable mixture models) and response mapping (ordered logistic regression and seemingly unrelated regression (SUR)) models were developed on the training sample. These were internally validated, and their performance evaluated on the testing sample. Model performance was evaluated over 100-fold repeated training-testing sample splits. For the EQ-5D-3L analysis, the multivariable linear and splines models had the lowest mean square error (MSE) of 0.0415. The SUR model had the lowest mean absolute error (MAE) of 0.136. Model performance was greatest in the mid-range and best health states, and lowest in poor health states. For the EQ-5D-5L analyses, the multivariable linear and splines models had the lowest MSE (0.0241-0.0278) while the SUR models had the lowest MAE (0.105-0.113). The developed models now allow accurate estimation of the EQ-5D health index when only the OSS responses are available as a measure of patient-reported health outcome.

Identifiants

pubmed: 36169788
doi: 10.1007/s11136-022-03262-4
pii: 10.1007/s11136-022-03262-4
pmc: PMC9911508
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-518

Informations de copyright

© 2022. The Author(s).

Références

Value Health. 2018 Jun;21(6):748-757
pubmed: 29909881
Orthop Res Rev. 2018 Feb 23;10:9-18
pubmed: 30774456
Health Qual Life Outcomes. 2020 Jun 15;18(1):184
pubmed: 32539838
Value Health. 2012 May;15(3):550-61
pubmed: 22583466
BMC Musculoskelet Disord. 2005 Feb 03;6:4
pubmed: 15691370
Health Technol Assess. 2020 Jun;24(34):1-68
pubmed: 32613941
Bone Joint J. 2017 Jan;99-B(1):107-115
pubmed: 28053265
Shoulder Elbow. 2016 Jul;8(3):203-14
pubmed: 27583021
Qual Life Res. 2013 Apr;22(3):665-75
pubmed: 22528239
JAMA. 2015 Mar 10;313(10):1037-47
pubmed: 25756440
Arthritis. 2013;2013:370231
pubmed: 23365745
Med Decis Making. 2006 Jan-Feb;26(1):18-29
pubmed: 16495197
Health Qual Life Outcomes. 2015 May 23;13:63
pubmed: 26001890
Health Qual Life Outcomes. 2015 Jan 23;13:6
pubmed: 25613110
Arch Orthop Trauma Surg. 2009 Jan;129(1):119-23
pubmed: 18183410
Iran J Med Sci. 2015 Sep;40(5):404-10
pubmed: 26379346
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
J Shoulder Elbow Surg. 2021 Apr;30(4):e147-e156
pubmed: 32750528
Pharmacoeconomics. 2015 Oct;33(10):985-91
pubmed: 26232201
Value Health. 2021 Mar;24(3):443-460
pubmed: 33641779
BMJ. 2019 Dec 18;367:l6705
pubmed: 31852675
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889
Qual Life Res. 2020 Jan;29(1):265-274
pubmed: 31541386

Auteurs

Epaminondas M Valsamis (EM)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK. markos.valsamis@ndorms.ox.ac.uk.

David Beard (D)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.

Andrew Carr (A)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.

Gary S Collins (GS)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Centre for Statistics in Medicine, University of Oxford, Oxford, OX3 7LD, UK.

Stephen Brealey (S)

Department of Health Sciences, York Trials Unit, University of York, York, YO10 5DD, UK.

Amar Rangan (A)

Department of Health Sciences, York Trials Unit, University of York, York, YO10 5DD, UK.

Rita Santos (R)

Centre for Health Economics, University of York, York, YO10 5DD, UK.

Belen Corbacho (B)

Department of Health Sciences, York Trials Unit, University of York, York, YO10 5DD, UK.

Jonathan L Rees (JL)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.

Rafael Pinedo-Villanueva (R)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH